These data are inconsistent with the study by Saiman et al., which demonstrated that inhibiting CXCR4 with AMD3100 increased liver fibrosis and increased transcript levels of Acta2 and Col1a1[42]. Here, ACTA2 is linked to Hepatic fibrosis.